1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Buprenorphine
Trade Name:
Probuphine
Manufacturer/Distributor:
Knight Therapeutics Inc.
Classification:
Opiate partial agonist
ATC Class:
N07BC01 - Buprenorphine
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/04/18
Date Marketed in Canada (yyyy/mm/dd):
2018/04/18
Presentation:
Implant: each rod contains 74.2 mg buprenorphine equivalent to 80 mg buprenorphine hydrochloride. DIN: 02474921
Comments:
Subdermal implant consisting of 4 rods of buprenorphine. To be used in opioid dependent patients who are clinically stabilized on no more than 8 mg sublingual buprenorphine. The implants are replaced every six months.
Back to:
Drug Product Listings 
